المؤلفون: Shamul JG, Shah SR, Kim J, Schiapparelli P, Vazquez-Ramos CA, Lee BJ, Patel KK, Shin A, Quinones-Hinojosa A, Green JJ

المصدر: International Journal of Nanomedicine, Vol Volume 14, Pp 10047-10060 (2019)

مصطلحات موضوعية: gbm, verteporfin, micelle, anisotropic, poly(ethylene glycol) (peg), poly(beta-amino ester) (pbae), Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/verteporfin-loaded-anisotropic-polybeta-amino-ester-based-micelles-dem-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013

URL الوصول: https://doaj.org/article/2496eb01f1894d55b0f3730a936e4f48

المؤلفون: Patel, KK, Gomes, MB, Charbonnel, B, Chen, HT, Cid-Ruzafa, J, Fenici, P, Hammar, N, Ji, LN, Kennedy, KF, Khunti, K, Kosiborod, M, Pocock, S, Shestakova, MV, Shimomura, I, Surmont, F, Watada, H, Arnold, SV

المصدر: Diabetes, obesity & metabolism. 23(1):39-48

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:144686460

المؤلفون: ABHIJIT KAR1, PATEL KK

المصدر: JOURNAL OF AGRISEARCH. 10

مصطلحات موضوعية: General Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0aa1584edb1d2d8516962dd971ca902f
https://doi.org/10.21921/jas.v10i01.12253

المؤلفون: Cowell W, Oscar Bertetto, Tim Maughan, George Fountzilas, Joseph McKendrick, Fareeda Y. Coxon, Chris Twelves, Eduardo Díaz-Rubio, Jim Cassidy, Dufour P, Patrick G. Johnston, Malzyner A, Arie Figer, Beham A, Patel Kk, Lesniewski-Kmak K, S. Jelic, Jean-Yves Douillard, Bustová I, Werner Scheithauer, Louis P. Garrison

المصدر: British Journal of Cancer

مصطلحات موضوعية: Oncology, Cancer Research, Time Factors, Cost effectiveness, Colorectal cancer, Cost-Benefit Analysis, Leucovorin, Administration, Oral, Deoxycytidine, pharmacoeconomics, Antineoplastic Combined Chemotherapy Protocols, Clinical Studies, health care economics and organizations, Remission Induction, Health Care Costs, Survival Rate, Treatment Outcome, colon cancer, Chemotherapy, Adjuvant, Fluorouracil, Colonic Neoplasms, Injections, Intravenous, Health Resources, medicine.drug, medicine.medical_specialty, Sensitivity and Specificity, Disease-Free Survival, Drug Administration Schedule, Drug Costs, RC0254, Capecitabine, Pharmacoeconomics, adjuvant, Internal medicine, medicine, Adjuvant therapy, Humans, cost-effectiveness, Survival rate, Neoplasm Staging, 5-fluorouracil/leucovorin, business.industry, medicine.disease, United Kingdom, Surgery, Oxaliplatin, Quality of Life, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54baae58ae640e5aac31eb57404fefd
https://doi.org/10.1038/sj.bjc.6603059

المؤلفون: SULLIVAN SD, JENSEN DM, BERNSTEIN DE, HASSANEIN TI, FOSTER GR, LEE SS, CHEINQUER H, COOKSLEY G, KLASKALA W, PETTIT K, PATEL KK, GREEN J., CRAXI, Antonio

المساهمون: SULLIVAN SD, JENSEN DM, BERNSTEIN DE, HASSANEIN TI, FOSTER GR, LEE SS, CHEINQUER H, CRAXI' A, COOKSLEY G, KLASKALA W, PETTIT K, PATEL KK, GREEN J

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3658::647898bf551ad13ce852be00f532181e
http://hdl.handle.net/10447/20684

المؤلفون: Sullivan, Sd, Crax, A, Alberti, Alfredo, Giuliani, G, DE CARLI, C, Wintfeld, N, Patel, Kk, Green, J.

المصدر: PharmacoEconomics. 22:477-479

مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, Interferon α-2b, Peginterferon α 2a, Interferon alpha-2, Antiviral Agents, Gastroenterology, Therapy naive, chemistry.chemical_compound, Internal medicine, Ribavirin, medicine, Humans, Pharmacology, Clinical Trials as Topic, business.industry, Health Policy, Public health, Public Health, Environmental and Occupational Health, Interferon-alpha, Health Care Costs, Hepatitis C, Hepatitis C, Chronic, medicine.disease, Recombinant Proteins, chemistry, Peginterferon alfa-2b, Drug Therapy, Combination, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab8f0d6e75881fef78fd67c8da984e1
https://doi.org/10.2165/00019053-200422070-00005

المؤلفون: J. Cassidy, Patel Kk, J.-Y. Douillard, F. Di Costanzo, Louis P. Garrison, Alberto Sobrero, G. Giuliani, Chris Twelves

المصدر: Journal of Clinical Oncology. 24:13518-13518

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Hospital setting, Adjuvant chemotherapy, medicine.medical_treatment, Surgery, Dukes c colon cancer, Capecitabine, Bolus (medicine), Oncology, Internal medicine, Concomitant, Economic evaluation, medicine, business, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8c87e0f10960a567a229591b11c47bf3
https://doi.org/10.1200/jco.2006.24.18_suppl.13518

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.